Home › Asthma › Texas

Pag-aaral pangklinika para sa Asthma sa Texas

20 pag-aaral para sa Asthma ang naghahanap ng mga kalahok sa mga site sa Texas.

Mga Lungsod sa Texas

Opisyal na teksto ng pag-aaral (English)

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

Research Site, Austin
Research Site, Boerne
Research Site, Dallas
at 6 pa

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06932263

A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)

GSK Investigational Site, Cypress
GSK Investigational Site, Tomball

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07645248

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

Enveda Investigative Site, McKinney

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07301255

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

Research Site 17, San Antonio
Research Site 07, Sugar Land

Nagre-recruitPhase 3

Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07359846

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

South Texas Medical Research Institute, Inc., DBA TTS Research, Boerne
Horizon Clinical Research Group, Cypress
Alina Clinical Trials, LLC., Dallas
at 2 pa

Nagre-recruitPhase 2

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06977581

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

Research Site, Dallas
Research Site, Houston
Research Site, San Antonio

Nagre-recruitPhase 3

Edad 5 hanggang 11 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06023589

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

Research Site 24, Amarillo
Research Site 19, Baytown
Research Site 07, Dallas
at 6 pa

Nagre-recruitPhase 3

Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07276724

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

GSK Investigational Site, Dallas
GSK Investigational Site, Kerrville

Nagre-recruitPhase 3

Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT05757102

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

Teva Investigational Site 12083, Austin
Teva Investigational Site 12060, Austin
Teva Investigational Site 12179, Cypress
at 13 pa

Nagre-recruitPhase 3

Edad 12 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT06664619

A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

Research Site, Lewisville
Research Site, San Antonio

Nagre-recruitPhase 2

Edad 4 hanggang 11 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07525375

A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

GSK Investigational Site, San Antonio

Nagre-recruitPhase 3

Edad 12 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07456033

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Research Site, Austin
Research Site, Baytown
Research Site, Beaumont
at 12 pa

Nagre-recruitPhase 3

Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Ago 13, 2026 · NCT06307665

A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283

GSK Investigational Site, Austin

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo

Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT07712393

A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma

Research site, Dallas
Research site, Houston
Research site, San Antonio

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT07532265

Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects

Orion Clinical Research, Austin
Pharmaceutical Research & Consulting, Inc., Dallas
Western Sky Medical Research, El Paso

Nagre-recruitObservasyonal na pag-aaral

Edad 5 hanggang 100 · Lahat ng kasarian · Na-update Hun 2, 2026 · NCT07228026

Escitalopram in Asthma Patients With Frequent Exacerbation

UT Southwestern, 1440 Empire Central, Ste. LD4.100, Dallas

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ene 26, 2026 · NCT06216535

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

Baylor College of Medicine, Houston

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 16, 2026 · NCT06273072

Individualizing Treatment for Asthma in Primary Care (Full Study)

JPS Health Network, Fort Worth
Kelsey Research Foundation, Houston

Nagre-recruitPhase 4

Edad 13 hanggang 75 · Lahat ng kasarian · Na-update Okt 29, 2025 · NCT07052942

Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study

University of Texas at Arlington, Arlington
Rebuilding Together North Texas, Plano

Nagre-recruit

Edad 5 pataas · Lahat ng kasarian · Na-update Okt 29, 2025 · NCT07196436

Viral Mucosal Reprogramming

University of Texas Medical Branch, Galveston

Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo

Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Ene 28, 2025 · NCT05331170

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.